MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke Recovery by Seini Moimoi | Mar 12, 2025 | Portfolio News
Inozyme Pharma Reports Full Year 2024 Financial Results and Announces Strategic Prioritization of ENPP1 Deficiency Pivotal Program and Recent Business Highlights by Seini Moimoi | Mar 10, 2025 | Portfolio News
Cohere Health and American Academy of Orthopaedic Surgeons Expand Collaboration to Drive Quality Musculoskeletal Care by Seini Moimoi | Mar 10, 2025 | Portfolio News
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering by Seini Moimoi | Mar 5, 2025 | Portfolio News
Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX) by Seini Moimoi | Feb 24, 2025 | Portfolio News
